CRISPRi screening identifies PIKfyve as a co‐therapeutic target for obinutuzumab

Yerim Kim(Hallym University), J. Oh(Yonsei University), Jeong Ryeol Kim(Yonsei University), Joo Young Kim(Yonsei University), Donghyuk Lee(University of California, Davis)
Clinical and Translational Medicine
May 1, 2025
Cited by 1


Related Papers